€8.40
1.55% yesterday
Madrid, Jan 30, 05:43 pm CET
ISIN
ES0171996087
Symbol
GRF
Sector
Industry

Grifols Stock price

€8.40
-0.78 8.54% 1M
-0.67 7.39% 6M
-0.75 8.18% YTD
-2.05 19.62% 1Y
-7.21 46.19% 3Y
-21.83 72.21% 5Y
-10.23 54.90% 10Y
Madrid, Closing price Thu, Jan 30 2025
-0.13 1.55%
ISIN
ES0171996087
Symbol
GRF
Sector
Industry

Key metrics

Market capitalization €5.71b
Enterprise Value €17.56b
P/E (TTM) P/E ratio 36.32
P/B ratio (TTM) P/B ratio 1.02
Cash position €644.94m
P/E forward 23.58
P/S forward 0.80
EV/Sales forward 2.46

Is Grifols a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,875 stocks worldwide.

Grifols Stock Analysis

Unlock Scores for Free

Analyst Opinions

14 Analysts have issued a Grifols forecast:

9x Buy
64%
4x Hold
29%
1x Sell
7%

Analyst Opinions

14 Analysts have issued a Grifols forecast:

Buy
64%
Hold
29%
Sell
7%

Financial data from Grifols

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
1,793 1,793
12% 12%
100%
- Direct Costs 1,066 1,066
10% 10%
59%
727 727
15% 15%
41%
- Selling and Administrative Expenses 211 211
9% 9%
12%
- Research and Development Expense 88 88
1% 1%
5%
428 428
22% 22%
24%
- Depreciation and Amortization 108 108
1% 1%
6%
EBIT (Operating Income) EBIT 319 319
31% 31%
18%
Net Profit 52 52
13% 13%
3%

In millions EUR.

Don't miss a Thing! We will send you all news about Grifols directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Nacho Abia
Employees 23,744
Founded 1940
Website www.grifols.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today